XN
Xencor, Inc.
XNCR · NASDAQ
$26.61 +3.10% (+$0.80)
1M +23.31%
Market Cap $1.97B
P/E Ratio -
Div. Yield -
ROE 28.66%
Bulios Fair Price
$13.56
49.0% downside
Current Price
$26.61
Undervalued Fair Value Overvalued
According to Bulios Fair Price, XNCR is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
26 /100
Expensive P/S 18.79x
P/B 3.92x
P/E N/A
Growth
1 /100
Declining Rev. growth 8.62%
Book val. growth 4.40%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 43.31%
Net margin 155.59%
Op. margin 205.84%
Quality
2 /100
Poor ROIC 33.91%
ROE 28.66%
ROA 22.53%
Debt
69 /100
Low Debt/Equity 0.13x
Current ratio 6.39x
Int. coverage -4.94x
Stability
37 /100
Moderate Beta 0.88x
Rev. volatility 27.17%
EPS volatility 97.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XNCR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bassil I. Dahiyat
Employees
260
Headquarters
Pasadena
Upcoming events
04 NOV
Earnings
Upcoming earnings report